Streetbeat News

Stock Prices

KHRNF

Khiron Life Sciences Corp. (OTC:KHRNF) has amended its agreement for the sale of its European subsidiaries, removing the option to acquire shares of its Colombian subsidiary, Zerenia S.A.S., to comply with TSX Venture Exchange conditions. The sale includes Pharmadrug Production GmbH and other entities, with regulatory approvals received and expected completion on November 17, 2023. Khiron's shares fell 11.3475% to $0.01 following the announcement.

Portfolio Pulse from Jelena Martinovic

November 17, 2023 | 5:11 pm

BBLG

BJ

CHPT

CYTO

GPS

TWST

ZENV

U.S. stocks were mostly flat, with the Dow slightly up and the NASDAQ marginally down. Energy shares surged by 2% while communication services fell by 0.9%. BJ's Wholesale Club Holdings Inc reported Q3 sales growth of 2.9% to $4.92 billion, missing estimates, but beat EPS expectations. The Gap, Inc. shares soared after strong Q3 results. Altamira Therapeutics Ltd. shares surged following a stake sale agreement. Twist Bioscience Corporation shares rose on robust quarterly results. Zenvia Inc., Bone Biologics Corporation, and ChargePoint Holdings, Inc. saw shares fall post-earnings or due to corporate announcements. Oil prices increased by 3.3%, while gold and silver saw slight declines.

Portfolio Pulse from Lisa Levin

November 17, 2023 | 5:10 pm

SPB

Spectrum Brands Holdings reported a year-over-year decline in Q4 revenue, leading to its shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 5:08 pm

FSR

Fisker Inc. (NYSE:FSR) stock continues to decline, dropping over 30% in the last five days following disappointing Q3 financial results and vehicle delivery numbers. Despite a one-day record of 107 vehicle deliveries, the company's stock is at an all-time low. Morgan Stanley analyst Adam Jonas downgraded the price target from $4 to $3. High short interest is noted with 41.64% of available shares sold short.

Portfolio Pulse from Erica Kollmann

November 17, 2023 | 5:06 pm

F

GM

STLA

UAW members at Stellantis NV (NYSE:STLA) have ratified a labor agreement with approximately 68% approval, ensuring a 25% wage increase through April 2028. The deal follows a six-week strike across Detroit Three automakers, including General Motors Co (NYSE:GM) and Ford Motor Co (NYSE:F), both of which have seen similar agreements favored by their UAW workers.

Portfolio Pulse from Shivani Kumaresan

November 17, 2023 | 5:05 pm

THC

Tenet Healthcare (THC) shares are up following the announcement of a deal to sell three of its hospitals in South Carolina to Novant Health for $2.4 billion in cash.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 5:05 pm

NTES

Over the past 3 months, 5 Wall Street analysts have provided ratings for NetEase (NASDAQ:NTES), with 4 being bullish and 1 somewhat bullish. The average price target is $132.4, representing an implied upside from the current price of $115.97. The average price target has increased by 5.08% over the past month.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

M

Telsey Advisory Group has maintained its Market Perform rating for Macy's (NYSE:M) and increased its price target from $14.00 to $15.00. Macy's shares are currently trading up 1.58% at $13.54, and the new price target suggests a potential upside of 10.78%. Macy's operates around 550 stores and a variety of e-commerce sites, with women's products making up 61% of its 2022 sales.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

NSSC

Needham has reaffirmed its Buy rating on NAPCO Security Techs (NASDAQ:NSSC) and increased its price target from $32.00 to $34.00. NAPCO's shares are currently trading at $27.68, and the new price target suggests a potential upside of 22.83%. NAPCO manufactures security products for various applications in commercial, residential, institutional, industrial, and governmental sectors.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

CAH

JP Morgan has maintained a Neutral rating for Cardinal Health (NYSE:CAH) and increased its price target from $101.00 to $112.00. Cardinal Health's shares are currently trading at $103.30, and the new price target suggests an 8.42% potential upside. Cardinal Health is a major player in the U.S. pharmaceutical wholesale industry, alongside Cencora and McKesson, and also supplies medical-surgical products globally.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm